Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade
Recruiting
Phase 1
Phase 2
Interventional Study
Neuromuscular Blocking Agents
Reversal of Neuromuscular Blockade
Recovery Time
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 59
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Universitas Padjadjaran · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In operating procedure with general anesthesia muscle relaxant is usually used to increase success rate of the operation and to give better outcome. The use of reversal drugs aims to reduce the risk of post-operative complications due to muscle relaxants. Neostigmine is commonly used as a reversal drug, but its indirect mechanism of action results in a long and unpredictable recovery time. Sugamma…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients who underwent laparoscopic cholecystectomy under general anesthesia
* Using muscle relaxant rocuronium
* Aged 18-59 years
* American Society of Anesthesiologists (ASA) physical status classification of 1 or 2.
Exclusion Criteria:
* History of drug allergies to the a…
Contacts